Antiplatelet therapy therapy warfarin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Blood Platelets Coronary Vessels

Diseases48

Hemorrhage Thrombosis Coronary Thrombosis Acute Coronary Syndrome Stroke Thromboembolism Myocardial Infarction Atrial Fibrillation Coronary Artery Disease Postoperative Hemorrhage Intracranial Hemorrhages Recurrence Embolism Coronary Restenosis Graft Occlusion, Vascular Ischemic Attack, Transient Intracranial Thrombosis Coronary Disease Brain Ischemia Cerebral Hemorrhage Hematoma Cerebrovascular Disorders Cardiovascular Diseases Blood Loss, Surgical Peripheral Vascular Diseases Gastrointestinal Hemorrhage Postoperative Complications Myocardial Ischemia Coronary Stenosis Intracranial Embolism Thrombocythemia, Essential Angina, Unstable Diabetic Angiopathies Arterial Occlusive Diseases Intracranial Aneurysm Ischemia Venous Thrombosis Thrombophlebitis Thrombocytopenia Carotid Stenosis Heart Diseases Purpura, Thrombocytopenic Carotid Artery Diseases Atherosclerosis Pulmonary Embolism Acute Disease Vitamin K Deficiency Oral Hemorrhage

Chemicals and Drugs49

Warfarin Platelet Aggregation Inhibitors Ticlopidine Aspirin Anticoagulants Phenprocoumon Purinergic P2Y Receptor Antagonists Receptors, Purinergic P2Y12 Thiophenes Vitamin K Epoxide Reductases Fibrinolytic Agents Dipyridamole Thienopyridines Tetrazoles Aryl Hydrocarbon Hydroxylases Platelet Glycoprotein GPIIb-IIIa Complex Acenocoumarol Pyridines beta-Alanine Vitamin K Sirolimus Pyridones Heparin Mixed Function Oxygenases Piperazines Purinergic P2 Receptor Antagonists Heparin, Low-Molecular-Weight Cardiovascular Agents Thromboxanes Rodenticides Adenosine Diphosphate Drug Combinations Immunoglobulin Fab Fragments Proton Pump Inhibitors Coated Materials, Biocompatible Vitamin K 1 Antithrombins Benzimidazoles 4-Hydroxycoumarins Thromboxane B2 Receptors, Purinergic P2 Sulfinpyrazone Adenosine Phosphodiesterase 3 Inhibitors Metals Carbon-Carbon Ligases Enoxaparin Phenylbutazone Phenazopyridine

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Drug Therapy, Combination Platelet Function Tests Stents Drug-Eluting Stents Treatment Outcome Angioplasty, Balloon, Coronary Risk Factors Prospective Studies Follow-Up Studies Percutaneous Coronary Intervention Risk Assessment Perioperative Care Prothrombin Time Administration, Oral Drug Monitoring Randomized Controlled Trials as Topic Retrospective Studies Thrombelastography Drug Administration Schedule Platelet Count Prosthesis Design Coronary Angiography Double-Blind Method Withholding Treatment Registries Incidence Clinical Trials as Topic Premedication Propensity Score Thrombolytic Therapy International Normalized Ratio Kaplan-Meier Estimate Chi-Square Distribution Cohort Studies Bleeding Time Postoperative Care Proportional Hazards Models Surgical Procedures, Elective Retreatment Angioscopy Vascular Surgical Procedures Angioplasty Endovascular Procedures Logistic Models Multivariate Analysis Surgical Procedures, Operative Blood Vessel Prosthesis Implantation Drug Dosage Calculations Endarterectomy, Carotid Risk Blood Vessel Prosthesis Embolization, Therapeutic Odds Ratio Clinical Protocols Angioplasty, Balloon Blood Transfusion Coronary Artery Bypass Pilot Projects Ultrasonography, Doppler, Transcranial Partial Thromboplastin Time Patient Selection Combined Modality Therapy Prognosis Myocardial Revascularization Tomography, X-Ray Computed Electrocardiography Predictive Value of Tests Cerebral Angiography Ultrasonography, Interventional Severity of Illness Index Research Design

Psychiatry and Psychology1

Medication Adherence

Phenomena and Processes18

Platelet Aggregation Platelet Activation Time Factors Drug Resistance Prothrombin Time Drug Interactions Platelet Count Dose-Response Relationship, Drug Blood Coagulation Chi-Square Distribution Bleeding Time Herb-Drug Interactions Vascular Patency Risk Odds Ratio Partial Thromboplastin Time Polymorphism, Genetic Genotype

Disciplines and Occupations3

Pharmacogenetics Evidence-Based Medicine Research Design

Technology, Industry, Agriculture1

Coated Materials, Biocompatible

Information Science2

Registries Incidence

Health Care38

Treatment Outcome Risk Factors Prospective Studies Follow-Up Studies Risk Assessment Secondary Prevention Perioperative Care Randomized Controlled Trials as Topic Retrospective Studies Double-Blind Method Withholding Treatment Point-of-Care Systems Practice Guidelines as Topic Registries Incidence Clinical Trials as Topic Propensity Score Kaplan-Meier Estimate Chi-Square Distribution Cohort Studies Postoperative Care Proportional Hazards Models Societies, Medical Physician's Practice Patterns Logistic Models Multivariate Analysis Risk Odds Ratio Medication Adherence Clinical Protocols Pilot Projects Patient Selection Age Factors Cost-Benefit Analysis Predictive Value of Tests Rodent Control Severity of Illness Index Comorbidity

Geographicals3

Japan United States France

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care Geographicals

Warfarin Platelet Aggregation Inhibitors Ticlopidine Aspirin Anticoagulants Hemorrhage Drug Therapy, Combination Thrombosis Platelet Function Tests Platelet Aggregation Coronary Thrombosis Phenprocoumon Purinergic P2Y Receptor Antagonists Stents Receptors, Purinergic P2Y12 Acute Coronary Syndrome Thiophenes Vitamin K Epoxide Reductases Drug-Eluting Stents Treatment Outcome Angioplasty, Balloon, Coronary Stroke Fibrinolytic Agents Thromboembolism Dipyridamole Blood Platelets Platelet Activation Thienopyridines Myocardial Infarction Risk Factors Atrial Fibrillation Time Factors Tetrazoles Aryl Hydrocarbon Hydroxylases Prospective Studies Platelet Glycoprotein GPIIb-IIIa Complex Follow-Up Studies Coronary Artery Disease Percutaneous Coronary Intervention Postoperative Hemorrhage Risk Assessment Secondary Prevention Drug Resistance Intracranial Hemorrhages Perioperative Care Prothrombin Time Administration, Oral Acenocoumarol Recurrence Drug Monitoring Randomized Controlled Trials as Topic Embolism Retrospective Studies Coronary Restenosis Thrombelastography Drug Interactions Pyridines Graft Occlusion, Vascular beta-Alanine Vitamin K Sirolimus Ischemic Attack, Transient Pyridones Drug Administration Schedule Platelet Count Heparin Prosthesis Design Mixed Function Oxygenases Piperazines Purinergic P2 Receptor Antagonists Intracranial Thrombosis Coronary Disease Coronary Angiography Brain Ischemia Heparin, Low-Molecular-Weight Cerebral Hemorrhage Dose-Response Relationship, Drug Pharmacogenetics Double-Blind Method Hematoma Withholding Treatment Cerebrovascular Disorders Blood Coagulation Point-of-Care Systems Cardiovascular Diseases Blood Loss, Surgical Peripheral Vascular Diseases Practice Guidelines as Topic Gastrointestinal Hemorrhage Cardiovascular Agents Thromboxanes Registries Rodenticides Incidence Clinical Trials as Topic Premedication Propensity Score Postoperative Complications Myocardial Ischemia Coronary Stenosis

No FAQ available that match "antiplatelet therapy therapy warfarin"